The notified body does not have to be involved in class I medical devices (except for sterile devices, reusable surgical instruments, and devices with measuring functions).
For other classes (class IIa, IIb, and Class III), the notified body will review the manufacturers’ clinical evaluation reports and supporting data as part of the clinical assessment procedure.
They verify and conclude whether the manufacturer followed relevant procedures, performs risk analysis and identify undesirable side effects, provides proper justification for benefits, adequately identifies, appraises, and analyze the clinical data, provides sufficient clinical evidence related to safety and performance, and demonstrate the equivalence for the device under evaluation.
They also examine:
- whether PMS plan is provided and if it is adequate and appropriate,
- the areas in the clinical evaluation which need to be confirmed using PMCF,
- whether the PMCF plan is correct,
- Justification is given in case PMCF is not necessary,
- identified the sources of data from the PMS system,
- whether risks are acceptable when weighed against the benefits and
- clinical performance of the device is achieved.
The notified body will confirm the validity of the manufacturer’s justification, estimate the associated risks, and finally write a Clinical Evaluation Assessment Report(CEAR) based on the assessment done.